Dimethyloxalylglycine Suppresses SREBP1c and Lipogenic Gene Expressions in Hepatocytes Independently of HIF1A

Dimethyloxalylglycine Suppresses SREBP1c and Lipogenic Gene Expressions in Hepatocytes Independently of HIF1A

Dimethyloxalylglycine (DMOG) is a representative inhibitor of the prolyl hydroxylase domain (PHD), which mediates the degradation of hypoxia-inducible factor-1-alpha (HIF1A). DMOG exerts its pharmacological effects via the canonical pathway that involves PHD inhibition; however, it remains unclear w...

Full description

Bibliographic Details
Main Authors:	Yong Seong Kwon, Ye Eun Cho, Yeonsoo Kim, Minseob Koh, Seonghwan Hwang
Format:	Article
Language:	English
Published:	MDPI AG 2024-03-01
Series:	Current Issues in Molecular Biology
Subjects:	dimethyloxalylglycine prolyl hydroxylase domain hypoxia-inducible factor-1-alpha fatty liver fatty acid synthesis sterol regulatory element-binding protein-1c
Online Access:	https://www.mdpi.com/1467-3045/46/3/151

Similar Items

SREBP-1-independent regulation of lipogenic gene expression in adipocytes
by: Motohiro Sekiya, et al.
Published: (2007-07-01)

Effect of Dimethyloxalylglycine on Stem Cells Osteogenic Differentiation and Bone Tissue Regeneration—A Systematic Review
by: Qiannan Dong, et al.
Published: (2024-03-01)

Targeting hypoxia-inducible factor-1 alpha suppresses Helicobacter pylori-induced gastric injury via attenuation of both cag-mediated microbial virulence and proinflammatory host responses
by: Jennifer M. Noto, et al.
Published: (2023-12-01)

Exploration of metabolic responses towards hypoxia mimetic DMOG in cancer cells by using untargeted metabolomics
by: Mohammad Imran Khan
Published: (2022-10-01)

Dimethyloxalylglycine Attenuates Steroid-Associated Endothelial Progenitor Cell Impairment and Osteonecrosis of the Femoral Head by Regulating the HIF-1α Signaling Pathway
by: Wenkai Shao, et al.
Published: (2023-03-01)

MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia
by: Courtney A Copeland, et al.
Published: (2023-07-01)

Dimethyloxalylglycine pretreatment of living donor alleviates both donor and graft liver ischemia-reperfusion injury in rats
by: Degong Jia, et al.
Published: (2024-01-01)

Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
by: Matthew E Cockman, et al.
Published: (2019-09-01)

HIF-PH Encoded by <i>EGLN1</i> Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia
by: Wancheng Guo, et al.
Published: (2022-06-01)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
by: Maria Savyuk, et al.
Published: (2020-07-01)

HIF-1α Directly Controls WNT7A Expression During Myogenesis
by: Federica Cirillo, et al.
Published: (2020-11-01)

SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression[S]
by: Laurent Vergnes, et al.
Published: (2016-03-01)

Dimethyloxalylglycine Promotes Bone Marrow Mesenchymal Stem Cell Osteogenesis via Rho/ROCK Signaling
by: Lei Zhang, et al.
Published: (2016-09-01)

A genetically encoded biosensor for visualising hypoxia responses in vivo
by: Tvisha Misra, et al.
Published: (2017-02-01)

Effect of Voacamine upon inhibition of hypoxia induced fatty acid synthesis in a rat model of methyln-nitrosourea induced mammary gland carcinoma
by: Lakhveer Singh, et al.
Published: (2021-06-01)

Dual regulation of mouse Δ5- and Δ6-desaturase gene expression by SREBP-1 and PPARα
by: Takashi Matsuzaka, et al.
Published: (2002-01-01)

Docosahexaneoic acid (22:6,n-3) regulates rat hepatocyte SREBP-1 nuclear abundance by Erk- and 26S proteasome-dependent pathways
by: Daniela Botolin, et al.
Published: (2006-01-01)

Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells
by: Peter A.C. Wing, et al.
Published: (2021-04-01)

Hypoxia Inducible Factor-1α Attenuates Ischemic Brain Damage by Modulating Inflammatory Response and Glial Activity
by: Nashwa Amin, et al.
Published: (2021-06-01)

Astragaloside IV restrains pyroptosis and fibrotic development of pulmonary artery smooth muscle cells to ameliorate pulmonary artery hypertension through the PHD2/HIF1α signaling pathway
by: Jie Xi, et al.
Published: (2023-10-01)

Network activity in primary hippocampal cultures upon HIF-prolyl hydroxylase inhibition
by: Savyuk, Maria Olegovna, et al.
Published: (2021-05-01)

The Effects of Synthetic SREBP-1 and PPAR-γ Decoy Oligodeoxynucleotide on Acne-like Disease In Vivo and In Vitro via Lipogenic Regulation
by: Hyemin Gu, et al.
Published: (2022-12-01)

Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver
by: Yiwei Zhu, et al.
Published: (2023-08-01)

IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells
by: Ishaiahu Shechter, et al.
Published: (2003-11-01)

miR‐17/20 Controls Prolyl Hydroxylase 2 (PHD2)/Hypoxia‐Inducible Factor 1 (HIF1) to Regulate Pulmonary Artery Smooth Muscle Cell Proliferation
by: Tianji Chen, et al.
Published: (2016-12-01)

L-mimosine and hypoxia can increase angiogenin production in dental pulp-derived cells
by: Klara Janjić, et al.
Published: (2017-05-01)

Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice
by: Jasper A. F. Demandt, et al.
Published: (2021-05-01)

Profile of Daprodustat in the Treatment of Renal Anemia Due to Chronic Kidney Disease
by: Ishii T, et al.
Published: (2021-02-01)

LRP5 Regulates HIF-1α Stability via Interaction with PHD2 in Ischemic Myocardium
by: Sujin Ju, et al.
Published: (2021-06-01)

Resveratrol Inhibits Proliferation and Induces Autophagy by Blocking SREBP1 Expression in Oral Cancer Cells
by: Masakatsu Fukuda, et al.
Published: (2022-11-01)

Repurposing Combination Therapy of Voacamine With Vincristine for Downregulation of Hypoxia-Inducible Factor-1α/Fatty Acid Synthase Co-axis and Prolyl Hydroxylase-2 Activation in ER+ Mammary Neoplasia
by: Lakhveer Singh, et al.
Published: (2021-11-01)

Disturbances in the normal regulation of SREBP-sensitive genes in PPARα-deficient mice
by: Dilip D. Patel, et al.
Published: (2001-03-01)

When is a target not a target?
by: David C Bersten, et al.
Published: (2019-09-01)

Prolyl hydroxylase inhibitor FG-4592 alleviates neuroinflammation via HIF-1/BNIP3 signaling in microglia
by: Qianqian Ruan, et al.
Published: (2024-04-01)

A novel small compound TOIDC suppresses lipogenesis via SREBP1-dependent signaling to curb MAFLD
by: Yaodi Shao, et al.
Published: (2022-12-01)

20(S)-protopanaxatriol inhibits liver X receptor α-mediated expression of lipogenic genes in hepatocytes
by: Gyun-Sik Oh, et al.
Published: (2015-06-01)

Long-Term Environmental Hypoxia Exposure and Haematopoietic Prolyl Hydroxylase-1 Deletion Do Not Impact Experimental Crohn’s Like Ileitis
by: Cara De Galan, et al.
Published: (2021-09-01)

WT1: The Hinge Between Anemia Correction and Cancer Development in Chronic Kidney Disease
by: Wen-Chin Lee, et al.
Published: (2022-04-01)

An Arabidopsis Prolyl 4 Hydroxylase Is Involved in the Low Oxygen Response
by: Anna Konkina, et al.
Published: (2021-03-01)

Structural Characterization of Hypoxia Inducible Factor α—Prolyl Hydroxylase Domain 2 Interaction through MD Simulations
by: Giorgia F. Camagni, et al.
Published: (2023-03-01)